Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 34, 2020 - Issue 20
366
Views
5
CrossRef citations to date
0
Altmetric
Short Communications

High ophiobolin A production in endophytic fungus Bipolaris sp. associated with Datura metel

, , , &
Pages 2990-2992 | Received 09 Dec 2018, Accepted 13 Mar 2019, Published online: 16 Apr 2019
 

Abstract

Ophiobolin A, a metabolite of fungi, is known to induce cell death and have anticancer activity. Therefore, obtaining ophiobolin A has become an important aspect in studying activity with medicinal properties that are affected by it. Ophiobolin A-producing filamentous fungi are endophytic or infectious microbes that attack annual and short-cycle plants. Here we isolated the endophyte of Datura metel, which is an annual plant that produces ophiobolin A. Results of this study have led to the identification of an endophytic filamentous fungus Bipolaris sp. with high ophiobolin A production (235 mg/L) in liquid culture after 21 days. Our findings further indicate that ophiobolin A-producing fungi live in short-cycle plants, and a method of finding the fungus is described.

Graphical Abstract

Acknowledgements

We would like to thank Prof. Kazuyoshi Ohashi and Prof. Hirotaka Shibuya for establishment of endophytic experimental system.

Disclosure statement

No potential conflict of interest was reported by the authors.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.